VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Patient access to non-opioid pain medicines; Issues related to FDA drug approval process; Copay accumulators and maximizers, HELP Copays Act (H.R. 830/S. 1375); General education about Alternative Funding Programs; General education about kidney disease, including APOL-1; H.R. 7085 - the BIOSECURE Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HANNAH BETH CORNWELL | — |
| ERIN MENDELSOHN | — |
| KRISTIN RICHTER | — |
| MATTHEW O SCHUMAKER | — |
| SWARNA VALLURUPALLI | — |
Taxation/Internal Revenue Code TAX
Issues related to corporate and international tax policy and research and development tax credits, American Innovation and R&D Competitiveness Act (H.R. 2673) and American Innovation and Jobs Act (S. 866)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW O SCHUMAKER | — |
| SWARNA VALLURUPALLI | — |
Medicare/Medicaid MMM
General education about federal policies impacting pharmaceutical development, approval, and reimbursement; Implementation of P.L. 117-169 provisions related to Medicare prescription drugs; Education about non-opioid pain therapies and Medicare beneficiary access to non-opioid medicines; H.R. 7142/S. 3832 - The Alternatives to PAIN Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HANNAH BETH CORNWELL | — |
| ERIN MENDELSOHN | — |
| KRISTIN RICHTER | — |
| MATTHEW O SCHUMAKER | — |
| SWARNA VALLURUPALLI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.